reproductive system
azoospermia
(
J:326601
)
• adult tamoxifen-treated males lack spermatozoa in the seminiferous tubule lumen
|
• adult tamoxifen-treated males show alterations in spermatid elongation resulting in aberrant spermatid morphology
|
• adult tamoxifen-treated males exhibit multinucleated round giant cells containing primary spermatocytes in most seminiferous tubules
|
• adult tamoxifen-treated males show abnormal tubule morphology features, including multinucleated rounded giant cells containing primary spermatocytes, a decreased number of elongated spermatids, and no spermatozoa in the lumen
|
small testis
(
J:326601
)
• adult tamoxifen-treated males exhibit a significantly smaller testis size than control males
|
• adult tamoxifen-treated males exhibit a significantly lower testis weight than control males
|
• adult tamoxifen-treated males show a 4.5-fold increase in the % of elongated spermatids with aberrant morphology relative to non-treated control males
|
cellular
azoospermia
(
J:326601
)
• adult tamoxifen-treated males lack spermatozoa in the seminiferous tubule lumen
|
• adult tamoxifen-treated males show alterations in spermatid elongation resulting in aberrant spermatid morphology
|
• adult tamoxifen-treated males exhibit multinucleated round giant cells containing primary spermatocytes in most seminiferous tubules
|
endocrine/exocrine glands
• adult tamoxifen-treated males show abnormal tubule morphology features, including multinucleated rounded giant cells containing primary spermatocytes, a decreased number of elongated spermatids, and no spermatozoa in the lumen
|
small testis
(
J:326601
)
• adult tamoxifen-treated males exhibit a significantly smaller testis size than control males
|
• adult tamoxifen-treated males exhibit a significantly lower testis weight than control males
|